COVID-19 and EQ-5D-5L health state valuation

被引:2
|
作者
Webb, Edward J. D. [1 ]
Kind, Paul [1 ,2 ]
Meads, David [1 ]
Martin, Adam [1 ]
机构
[1] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Hlth Econ, Leeds, England
[2] UCL, Inst Epidemiol & Hlth, London, England
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2024年 / 25卷 / 01期
关键词
COVID-19; EQ-5D-5L; Valuation; Visual analogue scale; Health shock; UK;
D O I
10.1007/s10198-023-01569-8
中图分类号
F [经济];
学科分类号
02 ;
摘要
BackgroundWe investigate whether and how general population health state values were influenced by the initial stages of the COVID-19 pandemic. Changes could have important implications, as general population values are used in health resource allocation.DataIn Spring 2020, participants in a UK general population survey rated 2 EQ-5D-5L states, 11111 and 55555, as well as dead, using a visual analogue scale (VAS) from 100 = best imaginable health to 0 = worst imaginable health. Participants answered questions about their pandemic experiences, including COVID-19's effect on their health and quality of life, and their subjective risk/worry about infection.AnalysisVAS ratings for 55555 were transformed to the full health = 1, dead = 0 scale. Tobit models were used to analyse VAS responses, as well as multinomial propensity score matching (MNPS) to create samples balanced according to participant characteristics.ResultsOf 3021 respondents, 2599 were used for analysis. There were statistically significant, but complex associations between experiences of COVID-19 and VAS ratings. For example, in the MNPS analysis, greater subjective risk of infection implied higher VAS ratings for dead, yet worry about infection implied lower ratings. In the Tobit analysis, people whose health was affected by COVID-19 rated 55555 higher, whether the effect on health was positive or negative.ConclusionThe results complement previous findings that the onset of the COVID-19 pandemic may have impacted EQ-5D-5L health state valuation, and different aspects of the pandemic had different effects.
引用
收藏
页码:117 / 145
页数:29
相关论文
共 50 条
  • [1] COVID-19 and EQ-5D-5L health state valuation
    Edward J. D. Webb
    Paul Kind
    David Meads
    Adam Martin
    [J]. The European Journal of Health Economics, 2024, 25 : 117 - 145
  • [2] THE VALUATION OF EQ-5D-5L HEALTH STATES IN KOREA
    Kim, S. H.
    Jo, M. W.
    Ahn, J.
    Shin, S.
    Ock, M.
    Park, J.
    Luo, N.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A753 - A753
  • [3] Valuation of the EQ-5D-5L in Taiwan
    Lin, Hsiang-Wen
    Li, Chia-Ing
    Lin, Fang-Ju
    Chang, Jen-Yu
    Gau, Churn-Shiouh
    Luo, Nan
    Pickard, A. Simon
    Goni, Juan M. Ramos
    Tang, Chao-Hsiun
    Hsu, Chien-Ning
    [J]. PLOS ONE, 2018, 13 (12):
  • [4] A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L
    Joel W. Hay
    Cynthia L. Gong
    Xiayu Jiao
    Nadine K. Zawadzki
    Roy S. Zawadzki
    A. Simon Pickard
    Feng Xie
    Samuel A. Crawford
    Ning Yan Gu
    [J]. Journal of General Internal Medicine, 2021, 36 : 1292 - 1301
  • [5] A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L
    Hay, Joel W.
    Gong, Cynthia L.
    Jiao, Xiayu
    Zawadzki, Nadine K.
    Zawadzki, Roy S.
    Pickard, A. Simon
    Xie, Feng
    Crawford, Samuel A.
    Gu, Ning Yan
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (05) : 1292 - 1301
  • [6] THE EFFECT OF POST COVID-19 REHABILITATION ON HEALTH STATUS USING THE EQ-5D-5L
    Williamson, T.
    Dyer, F.
    Garvey, D.
    Miers, A.
    Morris, C.
    Wells, C.
    Rahman, S.
    [J]. THORAX, 2021, 76 : A79 - A79
  • [7] EQ-5D-5L valuation study for Portugal
    Ferreira, Pedro L.
    Antunes, Patricia
    Ferreira, Lara N.
    Pereira, Luis N.
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87
  • [8] The EQ-5D-5L valuation study in Korea
    Seon-Ha Kim
    Jeonghoon Ahn
    Minsu Ock
    Sangjin Shin
    Jooyeon Park
    Nan Luo
    Min-Woo Jo
    [J]. Quality of Life Research, 2016, 25 : 1845 - 1852
  • [9] EQ-5D-5L Valuation for the Malaysian Population
    Shafie, Asrul Akmal
    Thakumar, Annushiah Vasan
    Lim, Ching Jou
    Luo, Nan
    Rand-Hendriksen, Kim
    Yusof, Faridah Aryani Md
    [J]. PHARMACOECONOMICS, 2019, 37 (05) : 715 - 725
  • [10] EQ-5D-5L VALUATION STUDY IN TAIWAN
    Lin, H.
    Li, C.
    Lin, F.
    Chang, J.
    Gau, C.
    Luo, N.
    Pickard, A. S.
    Goni, Ramos J. M.
    Tang, C.
    Hsu, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S91 - S91